Hypoglossal Nerve Stimulation

Hypoglossal Nerve Stimulation and Cardiovascular Disease Risk in Obstructive Sleep Apnea: A Comprehensive Review

By MedXY 07/24/2026

This review synthesizes current evidence on the impact of hypoglossal nerve stimulation (HGNS) on cardiovascular disease incidence in obstructive sleep apnea patients, highlighting potential long-term cardiovascular benefits and mechanistic insights.

news Otorhinolaryngology Respiratory

Hypoglossal Nerve Stimulation Significantly Lowers Hypoxic Burden and Improves Sleepiness in Obstructive Sleep Apnea Patients: Insights from the STAR Trial

By MedXY 07/13/2026

Hypoglossal nerve stimulation markedly reduces hypoxic burden in obstructive sleep apnea patients, correlating with improved daytime sleepiness independent of AHI changes, suggesting hypoxic burden as a complementary treatment outcome metric.

Neurology news Respiratory

Proximal Hypoglossal Nerve Stimulation Shows Promise for Moderate-to-Severe OSA in Landmark OSPREY Trial

By MedXY 04/24/2026

A recent randomized controlled trial demonstrates that proximal hypoglossal nerve stimulation significantly improves obstructive sleep apnea symptoms in patients intolerant to positive airway pressure therapy.